Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07614919

Preoperative Fasting Duration and Gastric Residue in Pediatric Upper Gastrointestinal Endoscopy

This retrospective observational study aims to evaluate the relationship between preoperative fasting duration and gastric residue in pediatric patients undergoing upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology. The study will assess the associations between gastric residue, gastrointestinal symptoms, underlying gastrointestinal diseases, and endoscopic findings. Data will be retrospectively collected from hospital records, anesthesia records, and endoscopy reports to investigate whether prolonged fasting duration reliably predicts an empty stomach in pediatric gastrointestinal patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

0 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital

Yıldırım, Bursa, 16310, Turkey (Türkiye)

Location contact

Gürcan Güler

CONTACT

[email protected]

+90 541 975 0407

About this study

Pulmonary aspiration is one of the most feared complications in pediatric anesthesia, and preoperative fasting is routinely used to reduce gastric content and aspiration risk. Current pediatric fasting guidelines support more liberal fasting regimens, especially for clear liquids, in order to avoid unnecessary prolonged fasting. However, prolonged fasting duration does not always guarantee an empty stomach, particularly in pediatric patients with gastrointestinal symptoms or underlying gastrointestinal pathology.

Recent studies evaluating gastric contents in children have mainly focused on gastric ultrasonography and estimated gastric volume in healthy pediatric populations. Data regarding directly observed gastric residue during upper gastrointestinal endoscopy in pediatric gastrointestinal patients remain limited.

This retrospective observational single-center study will include pediatric patients who underwent upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology between January 2025 and April 2026. Data will be retrospectively obtained from hospital information systems, anesthesia records, electronic medical records, and endoscopy reports.

Demographic characteristics, gastrointestinal symptoms, underlying gastrointestinal diseases, medication use, endoscopic findings, preoperative fasting duration, and endoscopically observed gastric residue will be evaluated. Gastric residue severity will be categorized as none, mild, moderate, or severe. In addition, clinically relevant residue will be defined as moderate or severe gastric residue.

The primary objective of the study is to evaluate the relationship between preoperative fasting duration and gastric residue severity. Secondary analyses will assess factors associated with clinically relevant gastric residue, including gastrointestinal inflammatory disease and other clinical variables.

The findings of this study may contribute to a better understanding of gastric residue patterns in pediatric gastrointestinal patients and support more individualized perioperative fasting assessment approaches.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pediatric patients aged under 18 years
  • Patients who underwent upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology
  • Patients with available hospital records, anesthesia records, and endoscopy reports
  • Patients with documented preoperative fasting duration
  • Patients with documented endoscopic assessment of gastric residue

Exclusion criteria

  • Patients aged 18 years or older
  • Patients with missing or incomplete data for key study variables
  • Patients without documented preoperative fasting duration
  • Patients without documented gastric residue assessment during endoscopy
  • Duplicate endoscopy records from the same patient, if only the first eligible procedure is included

Treatment and study plan

Upper gastrointestinal endoscopy

Procedure

Upper gastrointestinal endoscopy performed for evaluation of gastrointestinal symptoms or pathology in pediatric patients. The procedure was conducted under sedation or anesthesia according to institutional clinical practice. Endoscopic findings and endoscopically observed gastric residue were retrospectively evaluated from medical records and endoscopy reports.

Primary outcomes

  1. Gastric Residue Severity

    Time frame: At the time of upper gastrointestinal endoscopy

    Severity of endoscopically observed gastric residue during upper gastrointestinal endoscopy, categorized as none, mild, moderate, or severe according to endoscopic findings documented in medical records and endoscopy reports.

Secondary outcomes

  1. Clinically Relevant Gastric Residue

    Time frame: At the time of upper gastrointestinal endoscopy

    Presence of clinically relevant gastric residue during upper gastrointestinal endoscopy, defined as moderate or severe gastric residue based on endoscopic observation documented in medical and endoscopy records.

Study contacts

Contact information is provided by the study sponsor or research team.

Gürcan Güler

CONTACT

[email protected]

+90 541 975 0407

Sponsors and collaborators

Lead sponsor

Bursa Sevket Yilmaz Training and Research Hospital

Other Gov

Registry information

Official study title

Evaluation of Preoperative Fasting Duration and Gastric Residue in Children Undergoing Upper Gastrointestinal Endoscopy for Gastrointestinal Symptoms or Pathology

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 29, 2026
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.